Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...
Wall Street is falling following mixed profit reports from several big banks. The S&P 500 sank 1% Wednesday and was on track ...
Palantir's stock was a top performer in 2025.
Stock indexes gave up early gains and retreated on Tuesday as software stocks sold off after AI startup Anthropic released a preview of a new tool designed for a broader range of work-related tasks ...
Enterprise software stocks across the board are experiencing weakness to start the New Year's first day of market action, extending a trend that plagued much of the sector during 2025. In contrast, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results